Publications by the researcher in collaboration with Juan Rigoberto Tejedo Huaman (33)
2024
-
Protective effects of mesenchymal stromal cell-derived secretome on dermonecrosis induced in rabbits by Loxosceles intermedia spider venom
Journal of Venomous Animals and Toxins Including Tropical Diseases, Vol. 30
2023
-
Cell Therapy of Vascular and Neuropathic Complications of Diabetes: Can We Avoid Limb Amputation?
International Journal of Molecular Sciences, Vol. 24, Núm. 24
-
Rationale for combined therapies in severe-to-critical COVID-19 patients
Frontiers in Immunology, Vol. 14
-
Umbilical cord mesenchymal stromal cells transplantation delays the onset of hyperglycemia in the RIP-B7.1 mouse model of experimental autoimmune diabetes through multiple immunosuppressive and anti-inflammatory responses
Frontiers in Cell and Developmental Biology, Vol. 11
2022
-
Considerations for Clinical Use of Mesenchymal Stromal Cells
Handbook of Stem Cell Therapy: Volume 1 (Springer Nature), pp. 51-102
-
Health and economic burden due to malaria in Peru over 30 years (1990–2019): Findings from the global burden of diseases study 2019
The Lancet Regional Health - Americas, Vol. 15
-
Pdx1 Is Transcriptionally Regulated by EGR-1 during Nitric Oxide-Induced Endoderm Differentiation of Mouse Embryonic Stem Cells
International Journal of Molecular Sciences, Vol. 23, Núm. 7
2021
-
Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: study protocol for a randomized controlled double-blind phase II clinical trial (The NOMA Trial)
Trials, Vol. 22, Núm. 1
-
Stemness of human pluripotent cells: Hypoxia-like response induced by low nitric oxide
Antioxidants, Vol. 10, Núm. 9
2020
-
AICAR stimulates the pluripotency transcriptional complex in embryonic stem cells mediated by PI3K, GSK3β, and β-Catenin
ACS Omega, Vol. 5, Núm. 32, pp. 20270-20282
-
Corrigendum: Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus (Frontiers in Immunology, (2019), 10, 10.3389/fimmu.2019.01151)
Frontiers in Immunology
-
Mesenchymal Stromal Cell-Based Therapies as Promising Treatments for Muscle Regeneration After Snakebite Envenoming
Frontiers in Immunology, Vol. 11
2019
-
Cost-effective, safe, and personalized cell therapy for critical limb ischemia in type 2 diabetes mellitus
Frontiers in Immunology, Vol. 10, Núm. JUN
2017
-
Regulation of mitochondrial function and endoplasmic reticulum stress by nitric oxide in pluripotent stem cells
World Journal of Stem Cells, Vol. 9, Núm. 2, pp. 26-36
-
Zn2+ chelation by serum albumin improves hexameric Zn2+-insulin dissociation into monomers after exocytosis
PLoS ONE, Vol. 12, Núm. 11
2016
-
Differentiation of mouse embryonic stem cells toward functional pancreatic β-cell surrogates through epigenetic regulation of Pdx1 by nitric oxide
Cell Transplantation, Vol. 25, Núm. 10, pp. 1879-1892
-
Nitric Oxide Prevents Mouse Embryonic Stem Cell Differentiation Through Regulation of Gene Expression, Cell Signaling, and Control of Cell Proliferation
Journal of Cellular Biochemistry, pp. 2078-2088
2015
-
Using stem cells to produce insulin
Expert Opinion on Biological Therapy, Vol. 15, Núm. 10, pp. 1469-1489
2014
-
Impact of exposure to low concentrations of nitric oxide on protein profile in murine and human pancreatic islet cells
Islets, Vol. 6, Núm. 5
-
Nutrigenetics and nutrigenomics insights into diabetes etiopathogenesis
Nutrients, Vol. 6, Núm. 11, pp. 5338-5369